The resulting pre-miR-21 RIBOTAC efficiently recruited RNase L to induce catalytic degradation of pre-miR-21 in cancer cells, exhibiting nanomolar potency and enhanced efficacy compared with its parent binder. This evidence concerns the gene RNASEL and cancer.